MENU
GOSS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Gossamer Bio (GOSS) Earnings Date & Reports

Gossamer Bio Inc is a clinical-stage biopharmaceutical company... Show more

A.I. Advisor
published Earnings

GOSS is expected to report earnings to fall 20.24% to -16 cents per share on March 13

Gossamer Bio GOSS Stock Earnings Reports
Q4'25
Est.
$-0.17
Q3'25
Missed
by $0.02
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.02
The last earnings report on November 05 showed earnings per share of -20 cents, missing the estimate of -18 cents. With 2.32M shares outstanding, the current market capitalization sits at 579.80M.
View a ticker or compare two or three
GOSS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GOSS showed earnings on November 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a company, which engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
3013 Science Park Road
Phone
+1 858 684-1300
Employees
135
Web
https://www.gossamerbio.com